Search results
NIH Leader to Oversee Milken Institute School of P | Newswise
Newswise· 3 days agoWASHINGTON (June 4, 2024) — The Milken Institute School of Public Health at the George Washington University has named Timothy Holtz, global health epidemiologist, researcher, and board-certified ...
FDA Extends Upadacitinib Indications to Kids With Arthritis
Medscape· 3 days agoThe JAK inhibitor's safety profile for patients as young as 2 years was similar to known to the...
Challenges of caring for Alaskans: Fewer people, across more miles, often in cold, dark
San Francisco Chronicle· 3 days agoANCHORAGE, Alaska – When it comes to health care in rural America, every state faces...
Alvesco: Side effects and what to do about them
Medical News Today· 2 days agoAlvesco (ciclesonide) is a brand-name inhaled corticosteroid that’s prescribed for asthma in adults and certain children. As with other drugs, Alvesco...
Dermatology Goes “Global” | Newswise
Newswise· 2 days ago“Dr. Nadelman’s Global Dermatology experience was meaningful and beneficial both to him and the University of Michigan Dermatology program and to...
HIV/AIDS Fast Facts – KION546
KION 46 Salinas· 1 day agoAcute infection, or acute retroviral syndrome, which can produce flu-like symptoms in the first month after infection. Clinical latency, or asymptomatic...
County says it found no evidence of increased illness at South Bay Urgent Care tied to sewage spills
U-T San Diego· 5 days agoA close review of patient charts during that fortnight, said Dr. Mark Beatty, an assistant medical...
Challenges of caring for Alaskans: Fewer people, across more miles, often in cold, dark
San Antonio Express-News· 3 days agoANCHORAGE, Alaska – When it comes to health care in rural America, every state faces...
FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants
Fortune· 1 day ago“This is not a surprise; this is always in the cards,” Edwin Michael, PhD, an epidemiologist at the University of South Florida College of Public Health, tells Fortune. “The mutations will keep ...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 7 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely
